Clariane Future Growth
Future criteria checks 4/6
Clariane is forecast to grow earnings and revenue by 33% and 5.4% per annum respectively. EPS is expected to grow by 35.5% per annum. Return on equity is forecast to be 2% in 3 years.
Key information
33.0%
Earnings growth rate
35.5%
EPS growth rate
Healthcare earnings growth | 21.4% |
Revenue growth rate | 5.4% |
Future return on equity | 2.0% |
Analyst coverage | Good |
Last updated | 18 Dec 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 5,763 | 68 | 714 | 1,135 | 1 |
12/31/2025 | 5,534 | 84 | 567 | 889 | 7 |
12/31/2024 | 5,251 | 49 | 445 | 826 | 7 |
12/31/2023 | 4,992 | 20 | 317 | 730 | 7 |
6/30/2023 | 4,735 | 28 | 168 | 794 | N/A |
3/31/2023 | 4,587 | 32 | 204 | 828 | N/A |
12/31/2022 | 4,438 | 36 | 239 | 862 | N/A |
6/30/2022 | 4,288 | 85 | 348 | 900 | N/A |
3/31/2022 | 4,212 | 92 | 330 | 870 | N/A |
12/31/2021 | 4,137 | 100 | 311 | 840 | N/A |
9/30/2021 | 4,047 | 76 | 279 | 818 | N/A |
6/30/2021 | 3,941 | 60 | 243 | 785 | N/A |
3/31/2021 | 3,857 | 50 | 259 | 790 | N/A |
12/31/2020 | 3,773 | 39 | 275 | 795 | N/A |
9/30/2020 | 3,728 | 57 | 310 | 765 | N/A |
6/30/2020 | 3,683 | 74 | 346 | 734 | N/A |
3/31/2020 | 3,648 | 94 | 393 | 750 | N/A |
12/31/2019 | 3,613 | 115 | 439 | 766 | N/A |
9/30/2019 | 3,542 | 117 | 352 | 687 | N/A |
6/30/2019 | 3,471 | 119 | 264 | 607 | N/A |
3/31/2019 | 3,404 | 121 | 188 | 492 | N/A |
12/31/2018 | 3,336 | 123 | 113 | 377 | N/A |
9/30/2018 | 3,280 | 152 | 139 | 371 | N/A |
6/30/2018 | 3,224 | 180 | 165 | 364 | N/A |
3/31/2018 | 3,177 | 172 | 181 | 375 | N/A |
12/31/2017 | 3,131 | 163 | 197 | 385 | N/A |
9/30/2017 | 3,091 | 150 | 186 | 353 | N/A |
6/30/2017 | 3,052 | 137 | 176 | 320 | N/A |
3/31/2017 | 3,017 | 134 | N/A | 314 | N/A |
12/31/2016 | 2,981 | 131 | N/A | 307 | N/A |
9/30/2016 | 2,880 | 87 | N/A | 296 | N/A |
6/30/2016 | 2,779 | 42 | N/A | 284 | N/A |
3/31/2016 | 2,676 | 50 | N/A | 264 | N/A |
12/31/2015 | 2,573 | 59 | N/A | 245 | N/A |
9/30/2015 | 2,553 | 77 | N/A | 271 | N/A |
6/30/2015 | 2,533 | 95 | N/A | 297 | N/A |
3/31/2015 | 2,378 | 78 | N/A | 272 | N/A |
12/31/2014 | 2,222 | 61 | N/A | 247 | N/A |
9/30/2014 | 1,938 | 44 | N/A | 186 | N/A |
6/30/2014 | 1,654 | 27 | N/A | 126 | N/A |
3/31/2014 | 1,505 | 28 | N/A | 122 | N/A |
12/31/2013 | 1,356 | 29 | N/A | 119 | N/A |
9/30/2013 | 1,286 | 29 | N/A | 118 | N/A |
6/30/2013 | 1,216 | 29 | N/A | 118 | N/A |
3/31/2013 | 1,162 | 26 | N/A | 122 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLARIP's forecast earnings growth (33% per year) is above the savings rate (1.5%).
Earnings vs Market: CLARIP's earnings (33% per year) are forecast to grow faster than the UK market (10.3% per year).
High Growth Earnings: CLARIP's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CLARIP's revenue (5.4% per year) is forecast to grow faster than the UK market (3.8% per year).
High Growth Revenue: CLARIP's revenue (5.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CLARIP's Return on Equity is forecast to be low in 3 years time (2%).